Cargando…

Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic

PURPOSE: The aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care. METHODS: This study consisted of a web-based survey. The survey was anonymous and consisted of forty questions. RESULTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Žarković, M., Perros, P., Ćirić, J., Beleslin, B., Stojanović, M., Stojković, M., Miletić, M., Janić, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944403/
https://www.ncbi.nlm.nih.gov/pubmed/35325447
http://dx.doi.org/10.1007/s40618-022-01787-6
_version_ 1784673706481549312
author Žarković, M.
Perros, P.
Ćirić, J.
Beleslin, B.
Stojanović, M.
Stojković, M.
Miletić, M.
Janić, T.
author_facet Žarković, M.
Perros, P.
Ćirić, J.
Beleslin, B.
Stojanović, M.
Stojković, M.
Miletić, M.
Janić, T.
author_sort Žarković, M.
collection PubMed
description PURPOSE: The aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care. METHODS: This study consisted of a web-based survey. The survey was anonymous and consisted of forty questions. RESULTS: This survey included 206 respondents. 91.3% of the respondents had health insurance through the Republic Fund of Health Insurance, 9.7% had private or both health insurances, and 3.4% did not have any health insurance. A significant proportion of respondents (60.4%) had to switch from public to private health care to reach a physician and 73.8% had to switch from public to private laboratories. For the 91.9%, this was perceived as a financial burden. Before the pandemic, 83.1% of respondents reported regular follow-up by physicians, which decreased to 44.9% during the pandemic (p < 0.01). 76.3% of the respondents regarded that their thyroid disease was managed optimally before the pandemic, while this figure declined to only 48% during the pandemic (p < 0.01). CONCLUSIONS: The COVID-19 pandemic disrupted the medical care of thyroid patients in Serbia. For the patients treated in the public health care system, access to general practice was hindered, while access to specialist care was disrupted. It led to a switch from public to private health care, which was perceived as a financial burden for almost all the respondents. However, private health care proved to be an important safety net when the public system was overwhelmed.
format Online
Article
Text
id pubmed-8944403
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89444032022-03-24 Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic Žarković, M. Perros, P. Ćirić, J. Beleslin, B. Stojanović, M. Stojković, M. Miletić, M. Janić, T. J Endocrinol Invest Original Article PURPOSE: The aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care. METHODS: This study consisted of a web-based survey. The survey was anonymous and consisted of forty questions. RESULTS: This survey included 206 respondents. 91.3% of the respondents had health insurance through the Republic Fund of Health Insurance, 9.7% had private or both health insurances, and 3.4% did not have any health insurance. A significant proportion of respondents (60.4%) had to switch from public to private health care to reach a physician and 73.8% had to switch from public to private laboratories. For the 91.9%, this was perceived as a financial burden. Before the pandemic, 83.1% of respondents reported regular follow-up by physicians, which decreased to 44.9% during the pandemic (p < 0.01). 76.3% of the respondents regarded that their thyroid disease was managed optimally before the pandemic, while this figure declined to only 48% during the pandemic (p < 0.01). CONCLUSIONS: The COVID-19 pandemic disrupted the medical care of thyroid patients in Serbia. For the patients treated in the public health care system, access to general practice was hindered, while access to specialist care was disrupted. It led to a switch from public to private health care, which was perceived as a financial burden for almost all the respondents. However, private health care proved to be an important safety net when the public system was overwhelmed. Springer International Publishing 2022-03-24 2022 /pmc/articles/PMC8944403/ /pubmed/35325447 http://dx.doi.org/10.1007/s40618-022-01787-6 Text en © The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE) 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Žarković, M.
Perros, P.
Ćirić, J.
Beleslin, B.
Stojanović, M.
Stojković, M.
Miletić, M.
Janić, T.
Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic
title Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic
title_full Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic
title_fullStr Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic
title_full_unstemmed Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic
title_short Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic
title_sort health care access of thyroid disease patients in serbia during the covid-19 pandemic
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944403/
https://www.ncbi.nlm.nih.gov/pubmed/35325447
http://dx.doi.org/10.1007/s40618-022-01787-6
work_keys_str_mv AT zarkovicm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic
AT perrosp healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic
AT ciricj healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic
AT beleslinb healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic
AT stojanovicm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic
AT stojkovicm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic
AT mileticm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic
AT janict healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic